US 10202595
Chimeric clotting factors
granted A61KA61K38/36A61K38/4846
Quick answer
US patent 10202595 (Chimeric clotting factors) held by BIOVERATIV THERAPEUTICS INC. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/36, A61K38/4846, A61K47/62, A61P